University of Hamburg Medical Institutions
Hamburg, Germany
Location status: Recruiting
NCT Number: NCT04959604
The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative.
The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.
The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative.
The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.
Interested in participating?
Request Info18 year–100 year
All sexes
Interventional
Not applicable
Hamburg, Germany
Location status: Recruiting
Participants with a diagnosed (andeno)carcinoma of the ascending, transverse, descending and sigmoid colon will be included. Preoperatively the participants will receive an indocyanine green(ICG) injection at four points around the tumour endoscopically. The ICG marking will take place one to five days prior to surgery. In the draining lymph nodes of the specific region the ICG will accumulate and thus visible via fluorescence-camera during the surgery.
Intraoperatively, the precise locations of all fluorescent nodes will be documented photographically. A standard resection and lymph node dissection will be conducted, potential fluorescent nodes outside the standard resection lines will additionally be resected. The fresh specimen will then be measured, the fluorescent nodes marked and after the pathologic examination the nodes will be correlated to location, fluorescent yes/no and nodal positive/negative.
The aim ist not the visualization of the Sentinel node or the directly draining lymphatic vessel but all the nodes draining the peritumorous region at the point of surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Preoperatively the participants will receive an endoscopic marking at four points around the tumour with the fluorescent dye indocyanine green.
Time frame: intraoperative assessment
Counting ICG-positive sites intraoperatively
Time frame: video-analysis within one week after surgery
Counting ICG-positive sites video-analysis
Time frame: within one week after surgery
Picking ICG-positive lymph nodes ex vivo in unfixed specimen, sending ICG positive nodes separately to pathological examination
Time frame: within one week after surgery
ICG-positive sites outside standard resection area will be "cherry picked", sent to pathological examination separatively.
Contact information is provided by the study sponsor or research team.
Julia-Kristin Grass, Dr.
CONTACT
Katharina L Lucas, MD
CONTACT
Universitätsklinikum Hamburg-Eppendorf
Other
Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07283939
Ampulla of Vater Carcinoma, Appendiceal Neoplasms
Fairbanks, Alaska, United States
View Trial DetailsNCT07405476
Colon Carcinoma, Colonic Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT03026140
Colon Carcinoma, Colonic Diseases
Amsterdam, Netherlands
View Trial DetailsNCT06645808
Astrocytoma, Bladder Carcinoma
Groningen, Provincie Groningen, Netherlands
View Trial Details